Statistiche di base
| CIK | 1888014 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Akanda Corp.
SEC Filings (Chronological Order)
Questa pagina fornisce un elenco completo e cronologico dei depositi SEC, esclusi i documenti di proprietà che forniamo altrove.
| May 22, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2026 Commission File Number: 001-41324 AKANDA CORP. (Name of registrant) c/o Gowling WLG 100 King St. W, Suite 1600 Toronto, ON M5X 1G5 (Address of principal executive office) Indicate by c |
|
| May 22, 2026 |
Akanda Corp. Announces Cancellation of Special Meeting Exhibit 99.2 Akanda Corp. Announces Cancellation of Special Meeting Toronto, Ontario, May 22, 2026 – Akanda Corp. (Nasdaq: AKAN) (the “Company”) today announced the cancellation of the special meeting of shareholders that was to be held at 10:00 am est on Monday, May 25, 2026, which was originally scheduled for March 31, 2026, adjourned to Monday, April 27, 2026 and subsequently further adjourned. |
|
| May 22, 2026 |
Akanda Corp. Announces Receipt of NASDAQ Noncompliance Letter Exhibit 99.1 Akanda Corp. Announces Receipt of NASDAQ Noncompliance Letter TORONTO, ON May 22, 2026 — Akanda Corp. (NASDAQ: AKAN) (the “Company” or “Akanda”), today announced that the Company is not in compliance with the periodic filing requirements for continued listing set forth in Nasdaq Listing Rule 5250(c)(1) as a result of its failure to file its Annual Report on Form 20-F for the fiscal ye |
|
| May 13, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2026 Commission File Number: 001-41324 AKANDA CORP. (Name of registrant) c/o Gowling WLG 100 King St. W, Suite 1600 Toronto, ON M5X 1G5 (Address of principal executive office) Indicate by c |
|
| May 13, 2026 |
Notice of ADJOURNED Special Meeting of Shareholders Exhibit 99.1 Notice of ADJOURNED Special Meeting of Shareholders NOTICE IS HEREBY GIVEN THAT a special meeting of the shareholders (the "Meeting") of Akanda Corp. (the "Corporation") originally scheduled for March 31, 2026 (the “Original Meeting”), was adjourned (the “Adjournment”), to Monday, April 27, 2026 and subsequently adjourned (the "Second Adjournment") and will now be held at 10:00 am est |
|
| May 1, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): ☐ Form 10-K ☒ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: December 31, 2025 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 10-Q ☐ Transition Report o |
|
| April 29, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2026 Commission File Number: 001-41324 AKANDA CORP. (Name of registrant) c/o Gowling WLG 100 King St. W, Suite 1600 Toronto, ON M5X 1G5 (Address of principal executive office) Indicate by |
|
| April 29, 2026 |
Akanda Adjourns Shareholder Meeting Exhibit 99.1 Akanda Adjourns Shareholder Meeting Toronto, Ontario, April 29, 2026 – Akanda Corp. (NASDAQ: AKAN) (“Akanda” or the “Company”) today announced that on April 27, 2026, it convened and subsequently adjourned its Special Meeting of Shareholders (the “Meeting”) without transacting any business due to the absence of a quorum. The Meeting has been adjourned and will be reconvened in person |
|
| April 10, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2026 Commission File Number: 001-41324 AKANDA CORP. (Name of registrant) c/o Gowling WLG (Canada) LLP 100 King St. W, Suite 1600 Toronto, ON M5X 1G5, Canada (Address of principal executiv |
|
| April 10, 2026 |
Exhibit 99.1 Ontario Ministry of Government and Consumer Services Articles of Amendment Business Corporations Act Instructions For questions or more information to complete this form, please refer to the instruction page. Fields marked with an asterisk (") are mandatory. 1. Corporation Information Corporation Name* Akanda Corp, Ontario Corporation Number (OCN)* 2854618 Company Key 976898684 Offici |
|
| April 9, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2026 Commission File Number: 001-41324 AKANDA CORP. (Name of registrant) c/o Gowling WLG (Canada) LLP 100 King St. W, Suite 1600 Toronto, ON M5X 1G5, Canada (Address of principal executiv |
|
| April 9, 2026 |
Akanda Corp. Announces Reverse Stock Split Exhibit 99.1 Akanda Corp. Announces Reverse Stock Split TORONTO, ON April 9, 2026 — Akanda Corp. (NASDAQ: AKAN) (the “Company” or “Akanda”), today announced that it expects to implement a 1-for-4.5 reverse stock split of the Company’s common shares effective April 13, 2026. The reverse stock split was previously approved by the Company’s shareholders on November 28, 2025 and Board of Directors on |
|
| April 7, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2026 Commission File Number: 001-41324 AKANDA CORP. (Name of registrant) c/o Gowling WLG 100 King St. W, Suite 1600 Toronto, ON M5X 1G5 (Address of principal executive office) Indicate by |
|
| April 7, 2026 |
Akanda Adjourns Shareholder Meeting Exhibit 99.1 Akanda Adjourns Shareholder Meeting Toronto, Ontario, April 7, 2026 – Akanda Corp. (NASDAQ: AKAN) (“Akanda” or the “Company”) today announced that on March 31, 2026, it convened and subsequently adjourned its Special Meeting of Shareholders (the “Meeting”) without transacting any business due to the absence of a quorum. The Meeting has been adjourned and will be reconvened in person i |
|
| April 2, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2026 Commission File Number: 001-41324 AKANDA CORP. (Name of registrant) 100 King Street W, Suite 1600 Toronto, Ontario M5X 1G5, Canada (Address of principal executive office) Indicate |
|
| April 2, 2026 |
Exhibit 99.2 AKANDA CORP. Trader’s Bank Building 1100, 67 Yonge Street Form of Proxy – Special Meeting to be held on March 31, 2026 Print the name of the person you are appointing if this person is someone other than the Management Nominees listed herein: OR Appointment of Proxyholder I/We being the undersigned holder(s) of Akanda Corp. hereby appoint Jatinder Dhaliwal or failing this person, Kath |
|
| April 2, 2026 |
Exhibit 99.1 AKANDA CORP. NOTICE OF SPECIAL MEETING TO BE HELD ON MARCH 31, 2026 AND MANAGEMENT INFORMATION CIRCULAR FEBRUARY 26, 2026 AKANDA CORP. NOTICE OF SPECIAL MEETING OF SHAREHOLDERS (the “Notice”) NOTICE IS HEREBY GIVEN that a special meeting (the “Meeting”) of the holders (the “Shareholders”) of common shares (the “Common Shares”) of Akanda Corp. (the “Corporation”) will be held in person |
|
| March 31, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2026 Commission File Number: 001-41324 AKANDA CORP. (Exact Name of Registrant as Specified in Charter) Akanda Corp. 100 King Street W, Suite 1600 Toronto, Ontario M5X 1G5, Canada (Address |
|
| March 31, 2026 |
Exhibit 99.1 Akanda Corp. Driving Recurring Revenue Growth: $2 Million Cash Flow Secured Through Fiber Acquisition Toronto, Ontario-(Newsfile Corp. – March 26, 2026) - Akanda Corp. (NASDAQ: AKAN) (“Akanda”) and its wholly owned subsidiary, First Towers & Fiber Corp. (“FTF” or the “Company”), an emerging telecommunications infrastructure developer in Mexico, are pleased to announce an expansion of |
|
| March 20, 2026 |
As filed with the Securities and Exchange Commission on March 20, 2026 As filed with the Securities and Exchange Commission on March 20, 2026 Registration No. |
|
| March 4, 2026 |
As filed with the Securities and Exchange Commission on March 3, 2026 As filed with the Securities and Exchange Commission on March 3, 2026 Registration No. |
|
| February 27, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2026 Commission File Number: 001-41324 AKANDA CORP. (Exact Name of Registrant as Specified in Charter) Akanda Corp. 100 King Street W, Suite 1600 Toronto, Ontario M5X 1G5, Canada (Addr |
|
| February 27, 2026 |
First Towers & Fiber Corp. Owns The Largest Dark Fiber Network In Central Mexico Exhibit 99.1 First Towers & Fiber Corp. Owns The Largest Dark Fiber Network In Central Mexico Toronto, Ontario-(Newsfile Corp. – February 27, 2026) - Akanda Corp. (NASDAQ: AKAN) (“Akanda”) and its 100% owned subsidiary First Towers & Fiber Corp. (“FTF” or the “Company”), an emerging telecommunications infrastructure developer in Mexico, announced today plans to further expand the leasing of its ap |
|
| January 28, 2026 |
Exhibit 10.23 CONSULTING AGREEMENT IR Agency LLC (the “Consultant” or “IR Agency”) is pleased to provide certain consulting services to Akanda Corp (“you,” “Client” or “Company”) as more fully described in this agreement (the “Agreement”). This Agreement sets forth the terms and conditions pursuant to which Company engages Consultant to provide such services. 1. Consulting Services. (a) Commencing |
|
| January 28, 2026 |
As filed with the Securities and Exchange Commission on January 28, 2026 As filed with the Securities and Exchange Commission on January 28, 2026 Registration No. |
|
| January 26, 2026 |
As filed with the Securities and Exchange Commission on January 26, 2026 As filed with the Securities and Exchange Commission on January 26, 2026 Registration No. |
|
| January 26, 2026 |
CALCULATION OF FILING FEE TABLES AKANDA CORP. Table 1: Newly Registered and Carry Forward Securities Ex-Filing Fees CALCULATION OF FILING FEE TABLES F-1 AKANDA CORP. Table 1: Newly Registered and Carry Forward Securities Line Item Type Security Type Security Class Title Notes Fee Calculation Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Newly Registered Securities Fees to be Paid Equity Common Shares, no par va |
|
| January 23, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2026 Commission File Number: 001-41324 AKANDA CORP. (Name of registrant) 1a, 1b Learoyd Road New Romney TN28 8XU, United Kingdom (Address of principal executive office) Indicate by chec |
|
| January 23, 2026 |
Akanda Announces Closing of $7.0 Million Convertible Note Offering Exhibit 99.1 Akanda Announces Closing of $7.0 Million Convertible Note Offering Toronto, Ontario, January 23, 2026 (Newsfile) - Akanda Corp. (“Akanda” or the “Company”) (NASDAQ: AKAN) today announced the closing of its previously announced transaction with institutional investors for the purchase and sale of 12 month, convertible promissory notes for an aggregate purchase price of $7.0 million, in |
|
| January 21, 2026 |
Issuance of up to 3,752,212 Common Shares Akanda Corp. Prospectus Supplement No. 4 (To Prospectus dated September 29, 2025) Filed pursuant to Rule 424(b)(3) Registration Statement No. 333-290367 Issuance of up to 3,752,212 Common Shares Akanda Corp. This prospectus supplement (the “Prospectus Supplement”) is being filed to update and supplement our prospectus contained in our Registration Statement on Form F-1, dated September 29, 2025 (the “Prospectu |
|
| January 20, 2026 |
AKANDA CORP. UNSECURED CONVERTIBLE PROMISSORY NOTE Exhibit 10.2 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS NOTE NOR THE SECURITIES INTO WHICH THIS NOTE IS CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (A) IN THE ABSENCE OF (I) AN EFFECTIVE REGISTRATION STATEM |
|
| January 20, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2026 Commission File Number: 001-41324 AKANDA CORP. (Name of registrant) 100 King Street W, Suite 1600 Toronto, Ontario M5X 1G5, Canada (Address of principal executive office) Indicate |
|
| January 20, 2026 |
Akanda Announces $7.0 Million Convertible Note Offering Exhibit 99.1 Akanda Announces $7.0 Million Convertible Note Offering Toronto, Ontario, January 20, 2026 (Newsfile) - Akanda Corp. (“Akanda” or the “Company”) (NASDAQ: AKAN) today announced the execution of a securities purchase agreement with institutional investors for the purchase and sale of 12 month, convertible promissory notes for an aggregate purchase price of $7.0 million, in a private pla |
|
| January 20, 2026 |
exhibit 10.3 REGISTRATION RIGHTS AGREEMENT This REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of January [], 2026, is by and between Akanda Corp., a Canadian corporation (the “Company”), and each of the investors listed on the Schedule of Buyers attached to the Purchase Agreement (as defined below) (collectively, the “Investor”). RECITALS A. The Company and the Investor have entered i |
|
| January 20, 2026 |
Exhibit 10.1 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated as of January 20, 2026 (the “Subscription Date”), is by and among Akanda Corp., a corporation existing under the laws of the Province of Ontario with offices located at c/o Gowling WLG, 100 King St. W, Suite 1600, Toronto, ON M5X 1G5 (the “Company”), and each of the investors listed on the Sched |
|
| January 14, 2026 |
Issuance of up to 3,752,212 Common Shares Akanda Corp. Prospectus Supplement No. 3 (To Prospectus dated September 29, 2025) Filed pursuant to Rule 424(b)(3) Registration Statement No. 333-290367 Issuance of up to 3,752,212 Common Shares Akanda Corp. This prospectus supplement (the “Prospectus Supplement”) is being filed to update and supplement our prospectus contained in our Registration Statement on Form F-1, dated September 29, 2025 (the “Prospectu |
|
| January 8, 2026 |
Akanda Corp. Announces Reverse Stock Split Exhibit 99.1 Akanda Corp. Announces Reverse Stock Split TORONTO, ON January 8, 2026 — Akanda Corp. (NASDAQ: AKAN) (the “Company” or “Akanda”), today announced that it expects to implement a 1-for-5 reverse stock split of the Company’s common shares effective January 12, 2026. The reverse stock split was previously approved by the Company’s shareholders on November 28, 2025 and Board of Directors o |
|
| January 8, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2026 Commission File Number: 001-41324 AKANDA CORP. (Name of registrant) c/o Gowling WLG (Canada) LLP 100 King St. W, Suite 1600 Toronto, ON M5X 1G5, Canada (Address of principal execut |
|
| January 8, 2026 |
Exhibit 99.2 Ministry of Government and Consumer Services Articles of Amendment Business Corporations Act Instructions For questions or more information to complete this form, please refer to the instruction page. Fields marked with an asterisk ( * ) are mandatory. 1. Corporation Information Corporation Name * Akanda Corp. Company Key * Ontario Corporation Number (OCN) * 2854618 Official Email Add |
|
| December 22, 2025 |
Issuance of up to 18,761,062 Common Shares Akanda Corp. Prospectus Supplement No. 2 (To Prospectus dated September 29, 2025) Filed pursuant to Rule 424(b)(3) Registration Statement No. 333-290367 Issuance of up to 18,761,062 Common Shares Akanda Corp. This prospectus supplement (the “Prospectus Supplement”) is being filed to update and supplement our prospectus contained in our Registration Statement on Form F-1, dated September 29, 2025 (the “Prospect |
|
| December 18, 2025 |
Akanda Corp. Welcomes Momentum Towards Cannabis Reform in the United States Exhibit 99.1 Akanda Corp. Welcomes Momentum Towards Cannabis Reform in the United States Toronto, Ontario, December 18, 2025 (Business Wire) - Akanda Corp. (“Akanda” or the “Company”) (NASDAQ: AKAN) applauds the recent reports that US President Donald Trump and his administration are considering changes and the reclassification of federal cannabis policy in the USA, including potential reschedulin |
|
| December 18, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2025 Commission File Number: 001-41324 AKANDA CORP. (Name of registrant) c/o Gowling WLG (Canada) LLP 100 King St. W, Suite 1600 Toronto, ON M5X 1G5, Canada (Address of principal execu |
|
| December 2, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2025 Commission File Number: 001-41324 AKANDA CORP. (Name of registrant) 100 King Street W, Suite 1600 Toronto, Ontario M5X 1G5, Canada (Address of principal executive office) Indicate |
|
| November 13, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2025 Commission File Number: 001-41324 AKANDA CORP. (Name of registrant) 1a, 1b Learoyd Road New Romney TN28 8XU, United Kingdom (Address of principal executive office) Indicate by che |
|
| November 13, 2025 |
Akanda Researching Security Requirements For Full Cultivation License Exhibit 99.1 Akanda Researching Security Requirements For Full Cultivation License Toronto, Ontario-(Newsfile Corp. – November 13, 2025) - Akanda Corp. (NASDAQ: AKAN) (“Akanda” or the “Company”), is researching the security requirements and next steps for a full cultivation license through its cannabis operating subsidiary. Recently, the Company extended its option on its British Columbia asset fo |
|
| November 10, 2025 |
Exhibit 99.3 DN: AKANDA CORP. Form of Proxy – Special Meeting Adjournment to be held on November 28, 2025 Trader’s Bank Building 1100 , 67 Yonge Street Toronto ON M 5 E 1 J 8 Print the name of the person you are appointing if this person is someone other than the Management Nominees listed herein: Appointment of Proxyholder I/We being the undersigned holder(s) of Akanda Corp. hereby appoint Jatind |
|
| November 10, 2025 |
Notice of ADJOURNED Special Meeting of Shareholders Exhibit 99.1 Notice of ADJOURNED Special Meeting of Shareholders NOTICE IS HEREBY GIVEN THAT a special meeting of the shareholders (the “Meeting”) of Akanda Corp. (the “Corporation”) originally scheduled for October 30, 2025 (the “Original Meeting”), was adjourned (the “Adjournment”) until 10:00 a.m. (Eastern Time) on Friday, November 28, 2025 (the “Adjourned Meeting”) and will be held in person a |
|
| November 10, 2025 |
Exhibit 99.2 AKANDA CORP. NOTICE OF SPECIAL MEETING TO BE HELD ON OCTOBER 30, 2025 AND MANAGEMENT INFORMATION CIRCULAR SEPTEMBER 29, 2025 AKANDA CORP. NOTICE OF SPECIAL MEETING OF SHAREHOLDERS (the “Notice”) NOTICE IS HEREBY GIVEN that a special meeting (the “Meeting”) of the holders (the “Shareholders”) of common shares (the “Common Shares”) of Akanda Corp. (the “Corporation”) will be held in per |
|
| November 10, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2025 Commission File Number: 001-41324 AKANDA CORP. (Name of registrant) c/o Gowling WLG 100 King St. W, Suite 1600 Toronto, ON M5X 1G5 (Address of principal executive office) Indicate |
|
| October 31, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2025 Commission File Number: 001-41324 AKANDA CORP. (Name of registrant) 100 King Street W, Suite 1600 Toronto, Ontario M5X 1G5, Canada (Address of principal executive office) Indicate |
|
| October 20, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2025 Commission File Number: 001-41324 AKANDA CORP. (Name of registrant) 100 King Street W, Suite 1600 Toronto, Ontario M5X 1G5, Canada (Address of principal executive office) Indicate |
|
| October 20, 2025 |
Akanda Corp. Increasing Its Cannabis Investment Exhibit 99.1 Akanda Corp. Increasing Its Cannabis Investment Toronto, Ontario-(Newsfile Corp. - October 20, 2025) - Akanda Corp. (NASDAQ: AKAN) (“Akanda” or the “Company”), through its cannabis operating subsidiary, has furthered its cannabis investment by extending its option on its British Columbia asset for two additional years. The Company has been working on obtaining its full cultivation lic |
|
| October 17, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2025 Commission File Number: 001-41324 AKANDA CORP. (Name of registrant) 1a, 1b Learoyd Road New Romney TN28 8XU, United Kingdom (Address of principal executive office) Indicate by chec |
|
| October 17, 2025 |
Akanda To Accelerate Recurring Revenue with Expansion Of Up To 20 New Cellular Towers Exhibit 99.1 Akanda To Accelerate Recurring Revenue with Expansion Of Up To 20 New Cellular Towers Toronto, Ontario-(Newsfile Corp. - October 16, 2025) - Akanda Corp. (NASDAQ: AKAN) (“Akanda”) and its 100% owned subsidiary First Towers & Fiber Corp. (“FTF” or the “Company”), an emerging telecommunications infrastructure developer in Mexico, announced today a major network expansion initiative with |
|
| October 10, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2025 Commission File Number: 001-41324 AKANDA CORP. (Exact Name of Registrant as Specified in Charter) Akanda Corp. 100 King Street W, Suite 1600 Toronto, Ontario M5X 1G5, Canada (Addre |
|
| October 10, 2025 |
Exhibit 99.1 Akanda Corp. Addresses Impacts of Postal Strike on Receiving Materials for its Upcoming Special Meeting Toronto, Ontario, October 10, 2025 – Akanda Corp. (“Akanda” or the “Company”) today announced that, due to the ongoing postal strike in Canada, the Company is unable to mail shareholder proxy materials (the “Meeting Materials”) for its upcoming special meeting (the “Meeting”) of sha |
|
| October 9, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2025 Commission File Number: 001-41324 AKANDA CORP. (Name of registrant) 100 King Street W, Suite 1600 Toronto, Ontario M5X 1G5, Canada (Address of principal executive office) Indicate |
|
| October 9, 2025 |
Exhibit 99.1 AKANDA CORP. NOTICE OF SPECIAL MEETING TO BE HELD ON OCTOBER 30, 2025 AND MANAGEMENT INFORMATION CIRCULAR SEPTEMBER 29, 2025 AKANDA CORP. NOTICE OF SPECIAL MEETING OF SHAREHOLDERS (the “Notice”) NOTICE IS HEREBY GIVEN that a special meeting (the “Meeting”) of the holders (the “Shareholders”) of common shares (the “Common Shares”) of Akanda Corp. (the “Corporation”) will be held in per |
|
| October 9, 2025 |
Exhibit 99.2 DN: AKANDA CORP. Trader’s Bank Building 1100, 67 Yonge Street Toronto ON M5E 1J8 Form of Proxy – Special Meeting to be held on October 30, 2025 Print the name of the person you are appointing if this person is someone other than the Management Nominees listed herein: Appointment of Proxyholder I/We being the undersigned holder(s) of Akanda Corp. hereby appoint Jatinder Dhaliwal or fai |
|
| October 1, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2025 Commission File Number: 001-41324 AKANDA CORP. (Name of registrant) c/o Gowling WLG (Canada) LLP 100 King St. W, Suite 1600 Toronto, ON M5X 1G5, Canada (Address of principal exec |
|
| October 1, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2025 Commission File Number: 001-41324 AKANDA CORP. (Name of registrant) 1a, 1b Learoyd Road New Romney TN28 8XU, United Kingdom (Address of principal executive office) Indicate by ch |
|
| October 1, 2025 |
Exhibit 99.1 Akanda Corp. Unaudited Condensed Interim Consolidated Statements of Financial Position (Expressed in United States Dollars) June 30, December 31, As at Note 2025 2024 ASSETS Current Cash $ 2,523,719 $ 3,838,650 Cash held in trust 5,816 3,216 Trade and other receivables 7 4,097 370,537 Prepayments 42,915 391,649 Loans receivable 12,16 990,688 451,529 Total Current Assets 3,567,235 5,05 |
|
| October 1, 2025 |
Akanda Among the Leaders of Deployment in Mexico’s Largest Telecommunication Infrastructure Project Exhibit 99.1 Akanda Among the Leaders of Deployment in Mexico’s Largest Telecommunication Infrastructure Project Toronto, Ontario-(Newsfile Corp. – September 30, 2025) - Akanda Corp. (NASDAQ: AKAN) (“Akanda”) is pleased to report on the progress of its 100% owned subsidiary First Towers & Fiber Corp. (“FTF” or the “Company”). FTF, a leader in telecommunications infrastructure in Mexico, today anno |
|
| October 1, 2025 |
Issuance of up to 18,761,062 Common Shares Akanda Corp. Prospectus Supplement No. 1 (To Prospectus dated September 29, 2025) Filed pursuant to Rule 424(b)(3) Registration Statement No. 333-290367 Issuance of up to 18,761,062 Common Shares Akanda Corp. This prospectus supplement (the “Prospectus Supplement”) is being filed to update and supplement our prospectus contained in our Registration Statement on Form F-1, dated September 29, 2025 (the “Prospect |
|
| October 1, 2025 |
Issuance of up to 18,761,062 Common Shares Akanda Corp. Prospectus Filed Pursuant to Rule 424(b)(3) Registration No. 333-290367 Issuance of up to 18,761,062 Common Shares Akanda Corp. This prospectus relates to the resale, from time to time of up to an aggregate of 18,761,062 common shares, no par value, of Akanda Corp. (“Common Shares”), by the selling stockholders named elsewhere in this prospectus (“Selling Stockholders”). The Selling Stockholders m |
|
| October 1, 2025 |
Exhibit 10.1 CONSULTING AGREEMENT IR Agency LLC (the “Consultant” or “IR Agency”) is pleased to provide certain consulting services to Akanda Corp (“you,” “Client” or “Company”) as more fully described in this agreement (the “Agreement”). This Agreement sets forth the terms and conditions pursuant to which Company engages Consultant to provide such services. 1. Consulting Services. (a) Commencing |
|
| September 29, 2025 |
AKANDA CORP. c/o Gowling WLG (Canada) LLP 100 King St. W, Suite 1600 Toronto, ON M5X 1G5, Canada Tel: +1 (416) 862-7525 September 26, 2025 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F. St., N.E. Washington, D.C. 20549 Re: Request for Acceleration of Effectiveness of Registration Statement on Form F-1 (File No. 333-290367) Ladies and Gentlemen: Pu |
|
| September 29, 2025 |
X0101 EFFECT 33 LIVE 2025-09-29 16:00:00 F-1 0001888014 AKANDA CORP. 333-290367 |
|
| September 29, 2025 |
As filed with the Securities and Exchange Commission on September 29, 2025 As filed with the Securities and Exchange Commission on September 29, 2025 Registration No. |
|
| September 29, 2025 |
Exhibit 10.20 CONSULTING AGREEMENT IR Agency LLC (the “Consultant” or “IR Agency”) is pleased to provide certain consulting services to Akanda Corp (“you,” “Client” or “Company”) as more fully described in this agreement (the “Agreement”). This Agreement sets forth the terms and conditions pursuant to which Company engages Consultant to provide such services. 1. Consulting Services. (a) Commencing |
|
| September 26, 2025 |
AMENDMENT NO. 1 AMENDED AND RESTATED OPTION TO PURCHASE Exhibit 10.1 AMENDMENT NO. 1 TO AMENDED AND RESTATED OPTION TO PURCHASE This Amendment No. 1 to Amended and Restated Option to Purchase, dated as of September 24, 2025 (the “Amendment”), by and between 1107385 B.C. LTD., a British Columbia company having a mailing address of 800-1199 West Hastings St., Vancouver, BC V6E 3T5 (“Owner”) and Akanda Corp., an Ontario company having a mailing address of |
|
| September 26, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2025 Commission File Number: 001-41324 AKANDA CORP. (Name of registrant) 1a, 1b Learoyd Road New Romney TN28 8XU, United Kingdom (Address of principal executive office) Indicate by ch |
|
| September 24, 2025 |
September 24, 2025 Katie Field Interim Chief Executive Officer and Executive Director Akanda Corp. |
|
| September 18, 2025 |
Exhibit 10.3 Lock-Up Agreement August 18, 2025 AKANDA CORP. c/o Gowling WLG 100 King St. W, Suite 1600 Toronto, ON M5X 1G5 Re: Akanda Corp.—Lock-Up Agreement Ladies and Gentlemen: The undersigned is a holder of common shares, no par value (“Shares”), or rights to acquire Shares, including but not limited to Shares underlying Class A Special Shares and/or Class B Special Shares that may be issued t |
|
| September 18, 2025 |
Exhibit 10.4 Lock-Up Agreement August 18, 2025 AKANDA CORP. c/o Gowling WLG 100 King St. W, Suite 1600 Toronto, ON M5X 1G5 Re: Akanda Corp.—Lock-Up Agreement Ladies and Gentlemen: The undersigned is a holder of common shares, no par value (“Shares”), or rights to acquire Shares, including but not limited to Shares underlying Class A Special Shares and/or Class B Special Shares that may be issued t |
|
| September 18, 2025 |
CALCULATION OF FILING FEE TABLES AKANDA CORP. Table 1: Newly Registered and Carry Forward Securities Ex-Filing Fees CALCULATION OF FILING FEE TABLES F-1 AKANDA CORP. Table 1: Newly Registered and Carry Forward Securities Line Item Type Security Type Security Class Title Notes Fee Calculation Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Newly Registered Securities Fees to be Paid Equity Common Shares, no par va |
|
| September 18, 2025 |
Significant Subsidiaries of Akanda Corp. Exhibit 21.1 Significant Subsidiaries of Akanda Corp. Subsidiary Jurisdiction 1371011 BC Limited British Columbia, Canada 1468243 BC Limited British Columbia, Canada First Towers & Fiber Corp. British Columbia, Canada |
|
| September 18, 2025 |
As filed with the Securities and Exchange Commission on September 18, 2025 As filed with the Securities and Exchange Commission on September 18, 2025 Registration No. |
|
| September 16, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2025 Commission File Number: 001-41324 AKANDA CORP. (Name of registrant) c/o Gowling WLG (Canada) LLP 100 King St. W, Suite 1600 Toronto, ON M5X 1G5, Canada (Address of principal exec |
|
| September 16, 2025 |
Exhibit 10.1 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated as of September 11, 2025 (the “Subscription Date”), is by and among Akanda Corp., a corporation existing under the laws of the Province of Ontario with offices located at c/o Gowling WLG, 100 King St. W, Suite 1600, Toronto, ON M5X 1G5 (the “Company”), and each of the investors listed on the Sch |
|
| September 16, 2025 |
AKANDA CORP. UNSECURED CONVERTIBLE PROMISSORY NOTE Exhibit 10.2 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS NOTE NOR THE SECURITIES INTO WHICH THIS NOTE IS CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (A) IN THE ABSENCE OF (I) AN EFFECTIVE REGISTRATION STATEM |
|
| September 16, 2025 |
exhibit 10.3 REGISTRATION RIGHTS AGREEMENT This REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of September 11, 2025, is by and between Akanda Corp., a Canadian corporation (the “Company”), and each of the investors listed on the Schedule of Buyers attached to the Purchase Agreement (as defined below) (collectively, the “Investor”). RECITALS A. The Company and the Investor have entered |
|
| September 15, 2025 |
Akanda Announces $12.0 Million Convertible Note Offering Exhibit 99.1 Akanda Announces $12.0 Million Convertible Note Offering Toronto, Ontario, September 12, 2025 (Newsfile) - Akanda Corp. (“Akanda” or the “Company”) (NASDAQ: AKAN) today announced the execution and closing of a securities purchase agreement with institutional investors for the purchase and sale of 12 month, convertible promissory notes for an aggregate purchase price of up to $12.0 mil |
|
| September 15, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2025 Commission File Number: 001-41324 AKANDA CORP. (Name of registrant) c/o Gowling WLG 100 King St. W, Suite 1600 Toronto, ON M5X 1G5 (Address of principal executive office) Indicat |
|
| August 29, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2025 Commission File Number: 001-41324 AKANDA CORP. (Name of registrant) 100 King Street W, Suite 1600 Toronto, Ontario M5X 1G5, Canada (Address of principal executive office) Indicate b |
|
| August 22, 2025 |
Exhibit 10.4 DEBT SETTLEMENT AGREEMENT THIS DEBT SETTLEMENT AGREEMENT is made effective the 19th day of August 2025. BETWEEN: FIRST TOWERS & FIBERS CORP., a company incorporated pursuant to the laws of the Province of British Columbia (the “Company”) AND: DUNSTAN HOLDINGS LTD., a company incorporated pursuant to the laws of the Province of British Columbia (the “Creditor”) AND: AKANDA CORP., a com |
|
| August 22, 2025 |
Exhibit 99.2 Docusign Envelope ID: 2B493802 - 195D - 43E2 - B94A - 173A1C4C7D61 Docusign Envelope ID: 2B493802 - 195D - 43E2 - B94A - 173A1C4C7D61 Docusign Envelope ID: 2B493802 - 195D - 43E2 - B94A - 173A1C4C7D61 |
|
| August 22, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2025 Commission File Number: 001-41324 AKANDA CORP. (Name of registrant) 1a, 1b Learoyd Road New Romney TN28 8XU, United Kingdom (Address of principal executive office) Indicate by check |
|
| August 22, 2025 |
Exhibit 10.7 THIS SECURITY HAS NOT BEEN REGISTERED WITH THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITI |
|
| August 22, 2025 |
Exhibit 10.3 DEBT SETTLEMENT AGREEMENT THIS DEBT SETTLEMENT AGREEMENT is made effective the 19th day of August 2025. BETWEEN: FIRST TOWERS & FIBERS CORP., a company incorporated pursuant to the laws of the Province of British Columbia (the “Company”) AND: pgc finco inC. (as successor to PLENARY GROUP (CANADA) FINCO INC.), a company incorporated pursuant to the laws of the Province of British Colum |
|
| August 22, 2025 |
Exhibit 99.1 AKANDA CORP. ANNOUNCES CLOSING OF SHARE EXCHANGE WITH FIRST TOWERS AND FIBER CORP. First Towers develops, constructs and owns telecommunications infrastructure in Mexico Akanda Reaffirms its Continued Focus on the Growth of its Pre-Revenue Canadian Farming Property in British Columbia, at which the Company Plans to Develop THC and CBD Facilities Toronto, Ontario, August 22, 2025 (News |
|
| August 22, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2025 Commission File Number: 001-41324 AKANDA CORP. (Name of registrant) 100 King Street W, Suite 1600 Toronto, Ontario M5X 1G5, Canada (Address of principal executive office) Indicate b |
|
| August 22, 2025 |
Exhibit 10.5 THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS OR THE LAWS OF ANY OTHER JURISDICTION. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDE |
|
| August 22, 2025 |
Exhibit 10.2 REGISTRATION RIGHTS AGREEMENT This REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of August 19, 2025, is by and among Akanda Corp., a corporation existing under the laws of the Province of Ontario (the “Company”), and First Towers & Fiber Corp., a corporation existing under the laws of the Province of British Columbia (“First Towers”), on behalf of certain of the common sh |
|
| August 22, 2025 |
Akanda Corp. Announces Reverse Stock Split Exhibit 99.1 Akanda Corp. Announces Reverse Stock Split TORONTO, ON August 22, 2025 — Akanda Corp. (NASDAQ: AKAN) (the “Company” or “Akanda”), today announced that it expects to implement a 1-for-3.125 reverse stock split of the Company’s common shares effective August 26, 2025. The reverse stock split was previously approved by the Company’s shareholders on April 30, 2025 and Board of Directors o |
|
| August 22, 2025 |
Exhibit 10.8 GENERAL SECURITY AGREEMENT This General Security Agreement is made as of August 19, 2025 TO: 1353744 B.C. Ltd. (the “Lender”) RECITALS: A. Akanda Corp. (the “Borrower”) is, or may become, indebted or liable to the Lender pursuant to the terms of the Promissory Note. B. To secure the payment and performance of the Secured Liabilities, the Borrower has agreed to grant to the Lender the |
|
| August 22, 2025 |
Exhibit 10.6 THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS OR THE LAWS OF ANY OTHER JURISDICTION. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDE |
|
| August 22, 2025 |
SECOND AMENDMENT TO SHARE EXCHANGE AGREEMENT Exhibit 10.1 SECOND AMENDMENT TO SHARE EXCHANGE AGREEMENT This Second Amendment (this “Amendment”) to the Share Exchange Agreement dated as of March 5, 2025 and amended as of March 31, 2025 (the “Agreement”), among Akanda Corp., a corporation existing under the laws of the Province of Ontario, First Towers & Fiber Corp., a corporation existing under the laws of the Province of British Columbia, an |
|
| August 8, 2025 |
Exhibit 99.1 AKANDA CORP. NOTICE OF SPECIAL MEETING TO BE HELD ON AUGUST 29, 2025 AND MANAGEMENT INFORMATION CIRCULAR JULY 29, 2025 - i - AKANDA CORP. NOTICE OF SPECIAL MEETING OF SHAREHOLDERS (the “Notice”) NOTICE IS HEREBY GIVEN that a special meeting (the “Meeting”) of the holders (the “Shareholders”) of common shares (the “Common Shares”) of Akanda Corp. (the “Corporation”) will be held in per |
|
| August 8, 2025 |
Exhibit 99.2 DN: AKANDA CORP. Form of Proxy – Special Meeting to be held on August 29, 2025 Trader’s Bank Building 1100 , 67 Yonge Street Toronto ON M 5 E 1 J 8 Print the name of the person you are appointing if this person is someone other than the Management Nominees listed herein: Appointment of Proxyholder I/We being the undersigned holder(s) of Akanda Corp. hereby appoint Jatinder Dhaliwal or |
|
| August 8, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2025 Commission File Number: 001-41324 AKANDA CORP. (Name of registrant) c/o Gowling WLG 100 King St. W, Suite 1600 Toronto, ON M5X 1G5 (Address of principal executive office) Indicate b |
|
| May 1, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2025 Commission File Number: 001-41324 AKANDA CORP. (Name of registrant) 100 King Street W, Suite 1600 Toronto, Ontario M5X 1G5, Canada (Address of principal executive office) Indicate by c |
|
| April 30, 2025 |
CERTIFICATION PURSUANT TO RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934) Exhibit 12.2 CERTIFICATION PURSUANT TO RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934) I, Gurcharn Deol, certify that: 1. I have reviewed this Annual Report on Form 20-F of Akanda Corp.. 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circu |
|
| April 30, 2025 |
To the Board of Directors of Akanda Corp. Exhibit 15.1 To the Board of Directors of Akanda Corp. We hereby consent to the incorporation by reference in each of the Akanda Corp.’s Registration Statements on Form S-8 (No. 264450, No. 267976, No. 273245 and No. 279381) of our report dated April 30, 2024, relating to the consolidated financial statements of Akanda Corp., which appears in this Form 20-F. April 30, 2025 We have served as the Co |
|
| April 30, 2025 |
PURSUANT TO 18 U.S.C. SECTION 1350 Exhibit 13.2 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 In connection with the Annual Report on Form 20-F of Akanda Corp. (the “Company”) for the year ended December 31, 2024 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act o |
|
| April 30, 2025 |
PURSUANT TO 18 U.S.C. SECTION 1350 Exhibit 13.1 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 In connection with the Annual Report on Form 20-F of Akanda Corp. (the “Company”) for the year ended December 31, 2024 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act o |
|
| April 30, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F (Mark One) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXC |
|
| April 30, 2025 |
CERTIFICATION PURSUANT TO RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934) Exhibit 12.1 CERTIFICATION PURSUANT TO RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934) I, Katie Field, certify that: 1. I have reviewed this Annual Report on Form 20-F of Akanda Corp.. 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circums |
|
| April 18, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2025 Commission File Number: 001-41324 AKANDA CORP. (Name of registrant) 100 King Street W, Suite 1600 Toronto, Ontario M5X 1G5, Canada (Address of principal executive office) Indicate by |
|
| April 16, 2025 |
Exhibit 99.1 AKANDA CORP. NOTICE OF ANNUAL GENERAL AND SPECIAL MEETING TO BE HELD ON APRIL 30, 2025 AND MANAGEMENT INFORMATION CIRCULAR APRIL 11, 2025 - i - AKANDA CORP. NOTICE OF ANNUAL GENERAL AND SPECIAL MEETING OF SHAREHOLDERS (the “Notice”) NOTICE IS HEREBY GIVEN that an annual general and special meeting (the “Meeting”) of the holders (the “Shareholders”) of common shares (the “Common Shares |
|
| April 16, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2025 Commission File Number: 001-41324 AKANDA CORP. (Name of registrant) 100 King Street W, Suite 1600 Toronto, Ontario M5X 1G5, Canada (Address of principal executive office) Indicate by |
|
| April 16, 2025 |
Exhibit 99.2 |
|
| April 1, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2025 Commission File Number: 001-41324 AKANDA CORP. (Name of registrant) c/o Gowling WLG 100 King St. W, Suite 1600 Toronto, ON M5X 1G5 (Address of principal executive office) Indicate by |
|
| April 1, 2025 |
FIRST AMENDMENT TO SHARE EXCHANGE AGREEMENT Exhibit 10.2 FIRST AMENDMENT TO SHARE EXCHANGE AGREEMENT This First Amendment (this “Amendment”) to the Share Exchange Agreement (the “Agreement”) dated as of March 5, 2025 between Akanda Corp., a corporation existing under the laws of the Province of Ontario, and First Towers & Fiber Corp., a corporation existing under the laws of the Province of British Columbia, is made as of the 31st day of Ma |
|
| April 1, 2025 |
Exhibit 10.1 Akanda Corp. An Ontario corporation Offering of 226,668 Common Shares (Pursuant to Rule 506(b) of Regulation D) AN INVESTMENT IN THE SECURITIES INCLUDED IN THE OFFERING DESCRIBED HEREIN, INVOLVES RISK. INVESTORS SHOULD NOT INVEST ANY FUNDS IN THE OFFERING UNLESS YOU CAN AFFORD TO LOSE YOUR ENTIRE INVESTMENT. IN MAKING AN INVESTMENT DECISION, INVESTORS MUST RELY ON THEIR OWN EXAMINATIO |
|
| March 11, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2025 Commission File Number: 001-41324 AKANDA CORP. (Name of registrant) 1a, 1b Learoyd Road New Romney TN28 8XU, United Kingdom (Address of principal executive office) Indicate by check |
|
| March 11, 2025 |
Exhibit 99.1 SHARE EXCHANGE AGREEMENT THIS SHARE EXCHANGE AGREEMENT is made effective as of March 5, 2025 (the “Execution Date”) AMONG: AKANDA CORP., a corporation existing under the laws of the Province of Ontario (hereinafter referred to as “Purchaser”) AND: FIRST TOWERS & FIBERS CORP., a corporation existing under the laws of the Province of British Columbia (hereinafter referred to as “Company |
|
| March 11, 2025 |
Exhibit 99.2 AKANDA CORP. ANNOUNCES SHARE EXCHANGE AGREEMENT WITH FIRST TOWERS AND FIBER CORP. First Towers develops, constructs and owns telecommunications infrastructure in Mexico Akanda Reaffirms its Continued Focus on the Growth of its Pre-Revenue Canadian Farming Property in British Columbia, at which the Company Plans to Develop THC and CBD Facilities Intends to Discontinue and Cease its Bus |
|
| November 26, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2024 Commission File Number: 001-41324 AKANDA CORP. (Name of registrant) 1a, 1b Learoyd Road New Romney TN28 8XU, United Kingdom (Address of principal executive office) Indicate by che |
|
| November 26, 2024 |
Bridge LOAN Agreement FIRST TOWERS & FIBER CORP. – and – AKANDA CORP. November 21, 2024 Exhibit 10.1 Bridge LOAN Agreement BETWEEN FIRST TOWERS & FIBER CORP. – and – AKANDA CORP. November 21, 2024 Article 1 INTERPRETATION 1 1.1 Definitions 1 1.2 Certain Rules of Interpretation 5 1.3 Governing Law 5 1.4 Entire Agreement 5 1.5 Time of Day 6 1.6 Business Day 6 1.7 Conflicts 6 Article 2 loan 6 2.1 Loan 6 2.2 Purpose 6 2.3 Loan—Notice and Limitations 6 2.4 Funding of Loan 7 2.5 Lender’s R |
|
| November 12, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2024 Commission File Number: 001-41324 AKANDA CORP. (Name of registrant) 1a, 1b Learoyd Road New Romney TN28 8XU, United Kingdom (Address of principal executive office) Indicate by che |
|
| November 12, 2024 |
Exhibit 99.2 |
|
| November 12, 2024 |
Akanda Corp. Announces Reverse Stock Split Exhibit 99.1 Akanda Corp. Announces Reverse Stock Split LONDON, UK November 12, 2024 — Akanda Corp. (NASDAQ: AKAN) (the “Company” or “Akanda”), today announced that it expects to implement a 1-for-2 reverse stock split of the Company’s common shares effective November 14, 2024. The reverse stock split was previously approved by the Company’s shareholders on March 22, 2024 and Board of Directors on |
|
| October 30, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2024 Commission File Number: 001-41324 AKANDA CORP. (Name of registrant) 1a, 1b Learoyd Road New Romney TN28 8XU, United Kingdom (Address of principal executive office) Indicate by chec |
|
| October 30, 2024 |
Exhibit 99.1 Akanda Corp. Unaudited Condensed Interim Consolidated Statements of Financial Position (Expressed in United States Dollars) As at June 30, December 31, Note 2024 2023 ASSETS Current Cash $ 6,013,262 $ 82,816 Cash held in trust 18,720 11,059 Trade and other receivables 6 311,721 284,513 Prepayments 1,270,515 140,583 Inventory 7 – 1,286,894 Total Current Assets 7,614,218 1,805,865 Non-C |
|
| October 4, 2024 |
Akanda Corp. Announces Closing of Underwritten Public Offering Exhibit 99.1 Akanda Corp. Announces Closing of Underwritten Public Offering London, October 4, 2024 – On October 2, 2024, Akanda Corp. (“Akanda” or the “Company”) (NASDAQ: AKAN), an international medical cannabis company, entered into an underwriting agreement (the “Underwriting Agreement”) with Univest Securities, LLC (“Univest”) as the underwriter in connection with the issuance and sale by the |
|
| October 4, 2024 |
FORM OF PRE-FUNDED WARRANT TO PURCHASE COMMON SHARES AKANDA CORP. Exhibit 4.1 FORM OF PRE-FUNDED WARRANT TO PURCHASE COMMON SHARES AKANDA CORP. Warrant Shares: Initial Exercise Date: [] THIS PRE-FUNDED WARRANT TO PURCHASE COMMON SHARES (the “Warrant”) certifies that, for value received, [] or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date |
|
| October 4, 2024 |
AKANDA CORP. UNDERWRITING AGREEMENT Exhibit 1.1 EXECUTION VERSION AKANDA CORP. UNDERWRITING AGREEMENT October 2, 2024 Univest Securities, LLC 75 Rockefeller Plaza, Suite 1838 New York, NY 10019 As Representative of the Underwriters named on Schedule A hereto Ladies and Gentlemen: The undersigned, AKANDA CORP., a corporation organized under the laws of the Province of Ontario (collectively with its subsidiaries and affiliates, includ |
|
| October 4, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2024 Commission File Number: 001-41324 AKANDA CORP. (Name of registrant) 1a, 1b Learoyd Road New Romney TN28 8XU, United Kingdom (Address of principal executive office) Indicate by chec |
|
| October 3, 2024 |
Filed Pursuant to Rule 424(b)(4) Registration No. 333-281945 PROSPECTUS 258,940 Common Shares 1,241,060 Pre-Funded Warrants to Purchase 1,241,060 Common Shares 1,241,060 Common Shares Underlying the Pre-Funded Warrants Akanda Corp. We are offering 258,940 Common Shares, no par value (the “Common Shares”) at a public offering price of $1.00 per share. We are also offering 1,241,060 pre-funded warra |
|
| October 2, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2024 Commission File Number: 001-41324 AKANDA CORP. (Exact Name of Registrant as Specified in Charter) Akanda Corp. 1a, 1b Learoyd Road New Romney TN28 8XU, United Kingdom Tel: +44 (203 |
|
| October 2, 2024 |
Akanda Corp. Announces Pricing of Underwritten Public Offering Exhibit 99.1 Akanda Corp. Announces Pricing of Underwritten Public Offering London, October 2, 2024 – Akanda Corp. ("Akanda" or the “Company”) (NASDAQ: AKAN), an international medical cannabis company, today announced that it has entered into a firm commitment underwriting agreement with Univest Securities, LLC, as underwriter, whereby Univest has agreed to purchase 1,500,000 common shares (or pre |
|
| September 27, 2024 |
AKANDA CORP. 1a, 1b Learoyd Road New Romney, TN28 8XU, United Kingdom Tel: +44 (203) 488-9514 CORRESP 1 filename1.htm AKANDA CORP. 1a, 1b Learoyd Road New Romney, TN28 8XU, United Kingdom Tel: +44 (203) 488-9514 September 27, 2024 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F. St., N.E. Washington, D.C. 20549 Re: Request for Acceleration of Effectiveness of Registration Statement on Form F-1 (File No. 333-281945) Ladies and Gentlemen: Purs |
|
| September 27, 2024 |
September 27, 2024 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Re: Akanda Corp. Registration Statement on Form F-1, as amended File No. 333-281945 Request for Acceleration of Effective Date Ladies and Gentlemen: Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended (the |
|
| September 20, 2024 |
AKANDA CORP. UNDERWRITING AGREEMENT Exhibit 1.1 AKANDA CORP. UNDERWRITING AGREEMENT September [●], 2024 Univest Securities, LLC 75 Rockefeller Plaza, Suite 1838 New York, NY 10019 As Representative of the Underwriters named on Schedule A hereto Ladies and Gentlemen: The undersigned, AKANDA CORP., a corporation organized under the laws of the Province of Ontario (collectively with its subsidiaries and affiliates, including, without l |
|
| September 20, 2024 |
Exhibit 21.1 Subsidiaries Subsidiaries Jurisdiction of Incorporation Canmart Limited England and Wales Cannahealth Limited Malta Bophelo Holdings Ltd. United Kingdom Holigen Limited Malta 1468243 B.C. Ltd. Canada 1371011 B.C. Ltd Canada |
|
| September 20, 2024 |
As filed with the Securities and Exchange Commission on September 20, 2024 As filed with the Securities and Exchange Commission on September 20, 2024 Registration No. |
|
| September 16, 2024 |
Akanda Corp. Secures Hemp Cultivation License in Canada, Building on Previous Development Agreement Exhibit 99.1 Akanda Corp. Secures Hemp Cultivation License in Canada, Building on Previous Development Agreement London, United Kingdom – September 16, 2024 – Akanda Corp. (NASDAQ: AKAN), a global cannabis company, is excited to announce that it has obtained a license for hemp cultivation in Canada. This license is directly tied to Akanda’s previously announced agreement with 1107385 B.C. LTD, fur |
|
| September 16, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2024 Commission File Number: 001-41324 AKANDA CORP. (Exact Name of Registrant as Specified in Charter) Akanda Corp. 1a, 1b Learoyd Road New Romney TN28 8XU, United Kingdom Tel: +44 (2 |
|
| September 5, 2024 |
Exhibit 107 Calculation of Filing Fee Table Form F-1 (Form Type) Akanda Corp. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered and Carry Forward Securities Security Type Security Class Title Fee Calculation Rule or Carry Forward Rule Amount Registered(2) Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price(1) Fee Rate Amount of Registration Fee |
|
| September 5, 2024 |
Exhibit 21.1 Subsidiaries Subsidiaries Jurisdiction of Incorporation Canmart Limited England and Wales Cannahealth Limited Malta Bophelo Holdings Ltd. United Kingdom Holigen Holdings Limited Malta 1468243 B.C. Ltd. Canada 1371011 B.C. Ltd Canada |
|
| September 5, 2024 |
As filed with the Securities and Exchange Commission on September 5, 2024 As filed with the Securities and Exchange Commission on September 5, 2024 Registration No. |
|
| July 25, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2024 Commission File Number: 001-41324 AKANDA CORP. (Name of registrant) 1a, 1b Learoyd Road New Romney TN28 8XU, United Kingdom (Address of principal executive office) Indicate by check m |
|
| June 14, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2024 Commission File Number: 001-41324 AKANDA CORP. (Name of registrant) 1a, 1b Learoyd Road New Romney TN28 8XU, United Kingdom (Address of principal executive office) Indicate by check m |
|
| June 14, 2024 |
Akanda Corporation announces completion of F-3 shelf registration statement Exhibit 99.1 Akanda Corporation announces completion of F-3 shelf registration statement London, United Kingdom-(Newsfile Corp. - June 14, 2024) - Akanda Corp. (NASDAQ: AKAN) (“Akanda” or the “Company”), an international medical cannabis company, today announced that it has successfully completed sales of its securities under its existing Form F-3 shelf registration. The shelf registration stateme |
|
| June 12, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2024 Commission File Number: 001-41324 AKANDA CORP. (Name of registrant) 1a, 1b Learoyd Road New Romney TN28 8XU, United Kingdom (Address of principal executive office) Indicate by check m |
|
| June 12, 2024 |
Akanda Has Regained Compliance with Nasdaq’s Minimum Bid Price Requirement Exhibit 99.1 Akanda Has Regained Compliance with Nasdaq’s Minimum Bid Price Requirement London, UK, June 12, 2024 - Akanda Corp. (“Akanda” or the “Company”) (NASDAQ: AKAN), an international medical cannabis company, today announced that it has received a letter (the “Compliance Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market Inc. (“Nasdaq”) dated June 7, 2024, inform |
|
| May 23, 2024 |
AKANDA ANNOUNCES STOCK CONSOLIDATION Exhibit 99.1 AKANDA ANNOUNCES STOCK CONSOLIDATION London, UK May 21, 2024 –Akanda Corp. (“Akanda” or the “Company”) (NASDAQ: AKAN), an international medical cannabis company, reported that it expects to implement a 1-for-40 reverse stock split on its ordinary shares effective May 23, 2024, with trading to begin on a split-adjusted basis at the market open on that day. Trading in the ordinary share |
|
| May 23, 2024 |
Exhibit 99.2 |
|
| May 23, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2024 Commission File Number: 001-41324 AKANDA CORP. (Name of registrant) 1a, 1b Learoyd Road New Romney TN28 8XU, United Kingdom (Address of principal executive office) Indicate by check ma |
|
| May 20, 2024 |
Akanda Announces Closing of Subsequent Registered Direct Offering Exhibit 99.3 Akanda Announces Closing of Subsequent Registered Direct Offering London, UK May 20, 2024 – Akanda Corp. ("Akanda" or the “Company”), (NASDAQ: AKAN) an international medical cannabis company, today announced that it has closed its previously announced second registered direct offering for the sale and issuance of 2,491,381common shares at a purchase price of $0.1031 and 12,057,600 pre |
|
| May 20, 2024 |
Prospectus Supplement Filed pursuant to Rule 424(b)(5) (To Prospectus dated January 29, 2024) Registration No. |
|
| May 20, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2024 Commission File Number: 001-41324 AKANDA CORP. (Name of registrant) 1a, 1b Learoyd Road New Romney TN28 8XU, United Kingdom (Address of principal executive office) Indicate by check ma |
|
| May 20, 2024 |
Exhibit 1.1 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (this “Agreement”) is dated as of May , 2024, between Akanda Corp., a Canadian corporation incorporated under the Business Corporations Act (Ontario) (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”). W |
|
| May 20, 2024 |
Akanda Announces Closing of Registered Direct Offering Exhibit 99.1 Akanda Announces Closing of Registered Direct Offering London, May 17, 2024 – Akanda Corp. (“Akanda” or the “Company”), an international medical cannabis company, today announced that it has closed its previously announced registered direct offering for the sale and issuance of 2,491,381common shares at a purchase price of $0.1031 per share, and 21,756,922 pre-funded warrants to purch |
|
| May 20, 2024 |
Akanda Corp. Announces Subsequent Registered Direct Offering Exhibit 99.2 Akanda Corp. Announces Subsequent Registered Direct Offering London, May 17, 2024 – Akanda Corp. (“Akanda” or the “Company”), an international medical cannabis company, today announced that it has entered into a second securities purchase agreement with an accredited investor whereby the investor has agreed to purchase 2,491,381common shares at a purchase price of $0.1031 and 12,057,6 |
|
| May 20, 2024 |
FORM OF PRE-FUNDED WARRANT TO PURCHASE COMMON SHARES AKANDA CORP. Exhibit 4.1 FORM OF PRE-FUNDED WARRANT TO PURCHASE COMMON SHARES AKANDA CORP. Warrant Shares: Initial Exercise Date: May , 2024 THIS PRE-FUNDED WARRANT TO PURCHASE COMMON SHARES (the “Warrant”) certifies that, for value received, or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the |
|
| May 17, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2024 Commission File Number: 001-41324 AKANDA CORP. (Name of registrant) 1a, 1b Learoyd Road New Romney TN28 8XU, United Kingdom (Address of principal executive office) Indicate by check ma |
|
| May 17, 2024 |
Prospectus Supplement Filed pursuant to Rule 424(b)(5) (To Prospectus dated January 29, 2024) Registration No. |
|
| May 17, 2024 |
Akanda Corp. Announces Registered Direct Offering Exhibit 99.1 Akanda Corp. Announces Registered Direct Offering London, May 17, 2024 – Akanda Corp. ("Akanda" or the “Company”), an international medical cannabis company, today announced that it has entered into a securities purchase agreement with an accredited investor whereby the investor has agreed to purchase 2,491,381 common shares at a purchase price of $0.1031 and 21,756,922 pre-funded war |
|
| May 16, 2024 |
AKANDA CORP. RECEIVES NOTICE OF NON-COMPLIANCE FROM NASDAQ Exhibit 99.1 AKANDA CORP. RECEIVES NOTICE OF NON-COMPLIANCE FROM NASDAQ London, UK May 16, 2024 –Akanda Corp. ("Akanda" or the “Company”) (NASDAQ: AKAN), announced that it has received a deficiency notification letter from the Nasdaq Listing Qualifications Department on May 14, 2024, due to non-compliance with the minimum stockholders’ equity requirement as set forth in Nasdaq Listing Rule 5550(b) |
|
| May 16, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2024 Commission File Number: 001-41324 AKANDA CORP. (Name of registrant) 1a, 1b Learoyd Road New Romney TN28 8XU, United Kingdom (Address of principal executive office) Indicate by check ma |
|
| May 14, 2024 |
AKANDA CORP ANNOUNCES SETTLEMENT AGREEMENT WITH FORMER CEO TEJINDER VIRK Exhibit 99.1 AKANDA CORP ANNOUNCES SETTLEMENT AGREEMENT WITH FORMER CEO TEJINDER VIRK London, UK May 13, 2024 –Akanda Corp. (“Akanda” or the “Company”) (NASDAQ: AKAN), today announced a settlement agreement with former chief executive officer and director, Tejinder Virk, concluding a series of disputes that commenced following Mr. Virk’s resignation on February 3, 2023. The settlement resolves all |
|
| May 14, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2024 Commission File Number: 001-41324 AKANDA CORP. (Name of registrant) 1a, 1b Learoyd Road New Romney TN28 8XU, United Kingdom (Address of principal executive office) Indicate by check ma |
|
| May 13, 2024 |
As filed with the Securities and Exchange Commission on May 13, 2024 As filed with the Securities and Exchange Commission on May 13, 2024 Registration No. |
|
| May 13, 2024 |
Exhibit 107 Calculation of Filing Fee Tables Form S-8 (Form Type) Akanda Corp. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Proposed Maximum Maximum Security Fee Calculation Amount Offering Price Per Aggregate Offering Amount of Registration Security Type Class Title Rule Registered(1) Unit(3) Price(3) Fee Rate Fee Equity Common Shares(2) 457(c) and 4 |
|
| May 10, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2024 Commission File Number: 001-41324 AKANDA CORP. (Name of registrant) 1a, 1b Learoyd Road New Romney TN28 8XU, United Kingdom (Address of principal executive office) Indicate by check ma |
|
| May 10, 2024 |
Exhibit 99.1 Akanda Corp. Announces Plans to Be Among International First Movers Pending Completion of Landmark Change in US Drug Policy London, United Kingdom-(Newsfile Corp. – May 10, 2024) - Akanda Corp. (NASDAQ: AKAN) (“Akanda” or the “Company”), an international medical cannabis company, today announces it is actively following the landmark change in federal US policy to reschedule cannabis u |
|
| May 1, 2024 |
Exhibit 13.2 Certification of the Chief Financial Officer as required by Rule 13a-14(b) of the Securities Exchange Act of 1934 Pursuant to the requirement set forth in Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and Section 1350 of Chapter 63 of Title 18 of the United States Code (18 U.S.C. §1350), Gurcharn Deol, Chief Financial Officer of Akanda Corp. ( |
|
| May 1, 2024 |
Exhibit 12.2 Certification of the Chief Financial Officer as required by Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934 I, Gurcharn Deol, certify that: 1. I have reviewed this annual report on Form 20-F of Akanda Corp; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements mad |
|
| May 1, 2024 |
Exhibit 12.1 Certification of the Chief Executive Officer as required by Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934 I, Katie Field, certify that: 1. I have reviewed this annual report on Form 20-F of Akanda Corp; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, |
|
| May 1, 2024 |
Exhibit 13.1 Certification of the Chief Executive Officer as required by Rule 13a-14(b) of the Securities Exchange Act of 1934 Pursuant to the requirement set forth in Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and Section 1350 of Chapter 63 of Title 18 of the United States Code (18 U.S.C. §1350), Katie Field, Interim Chief Executive Officer and Directo |
|
| May 1, 2024 |
Exhibit 2.1 DESCRIPTION OF THE REGISTRANT’S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 As of April 30, 2024, Akanda Corp. (the “Company”, “we”, “us” and “our”) had the following series of securities that were outstanding and registered pursuant to Section 12(b) of the Securities Exchange Act of 1934, as amended, or the Exchange Act: Title of each class Trad |
|
| May 1, 2024 |
DATED 15 JANUARY 2024 Settlement agreement CANMART LTD AKANDA CORP MR. TREVOR SCOTT Exhibit 4.33 [***] Certain information in this document has been excluded pursuant to Regulation S-K, Item 601(b)(10). Such excluded information is not material and would likely cause competitive harm if publicly disclosed. DATED 15 JANUARY 2024 Settlement agreement between CANMART LTD and AKANDA CORP and MR. TREVOR SCOTT This agreement is dated 2024 Parties (1) CANMART LTD incorporated and regist |
|
| May 1, 2024 |
RESIGNATION AND MUTUAL RELEASE Exhibit 4.32 RESIGNATION AND MUTUAL RELEASE THIS AGREEMENT, dated April 24, 2024 (the “Effective Date”), is made by and between Harvinder Singh (the “Individual”) and Akanda Corp. (the “Company”). In consideration of the terms and conditions contained in this Agreement, the parties hereby agree as follows: 1. Resignation. The Individual hereby resigns as a director and officer of the Company, effe |
|
| May 1, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F (Mark One) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXC |
|
| May 1, 2024 |
INSIDER TRADING POLICY (Adopted as of November 14, 2021) Exhibit 11.4 INSIDER TRADING POLICY (Adopted as of November 14, 2021) I. SUMMARY Preventing insider trading is necessary to comply with securities laws and to preserve the reputation and integrity of Akanda Corp. (together with its subsidiaries, the “Company”) as well as that of all persons affiliated with the Company. “Insider trading” occurs when any person purchases or sells a security while in |
|
| May 1, 2024 |
AKANDA CORP. 2024 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS: february 26, 2024 Exhibit 4.31 AKANDA CORP. 2024 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS: february 26, 2024 1. GENERAL. (a) Eligible Award Recipients. Employees, Officers, Directors and Consultants are eligible to receive Awards. (b) Available Awards. The Plan provides for the grant of the following types of Awards: (i) Stock Options, and (ii) Restricted Share Unit Awards. (c) Purpose. The Plan, thr |
|
| May 1, 2024 |
To the Board of Directors of Akanda Corp. Exhibit 15.1 To the Board of Directors of Akanda Corp. We hereby consent to the incorporation by reference in each of the Akanda Corp.’s Registration Statements on Form S-8 (No. 264450, No. 267976 and No. 273245) of our report dated April 30, 2024, relating to the consolidated financial statements of Akanda Corp., which appears in this Form 20-F. May 1, 2024 We have served as the Company’s auditor |
|
| May 1, 2024 |
AKANDA CORP. INCENTIVE COMPENSATION RECOVERY POLICY Exhibit 97.1 AKANDA CORP. INCENTIVE COMPENSATION RECOVERY POLICY The Board of Directors (the “Board”) of Akanda Corp. (the “Company”) has adopted this Incentive Compensation Recovery Policy (the “Policy”), effective as of December 1, 2023 (the “Effective Date”). Capitalized terms used in this Policy that are not defined elsewhere in the text of this Policy are defined in Section 12. 1. Persons Sub |
|
| April 30, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING OMB APPROVAL OMB Number: 3235-0058 Expires: April 30, 2025 Estimated average burden hours per response 2.50 SEC FILE NUMBER CUSIP NUMBER (Check one): ☐ Form 10-K ☒ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form 10-D ☐ Form N-CEN ☐ Form N-CSR For Period Ended: December 31, 2023 ☐ Transition Rep |
|
| April 26, 2024 |
AKANDA APPOINTS COOPER TO THE BOARD OF DIRECTORS Exhibit 99.1 AKANDA APPOINTS COOPER TO THE BOARD OF DIRECTORS London, UK April 25, 2024 –Akanda Corp. (“Akanda” or the “Company”) (NASDAQ: AKAN), an international medical cannabis company, Akanda Corp. announces the appointment of Christopher Cooper to its board of directors following the resignation of Harvinder Singh as a director. Mr. Christopher Cooper has over 20 years of extensive business e |
|
| April 26, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2024 Commission File Number: 001-41324 AKANDA CORP. (Name of registrant) 1a, 1b Learoyd Road New Romney TN28 8XU, United Kingdom (Address of principal executive office) Indicate by check |
|
| April 15, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2024 Commission File Number: 001-41324 AKANDA CORP. (Name of registrant) 1a, 1b Learoyd Road New Romney TN28 8XU, United Kingdom (Address of principal executive office) Indicate by check |
|
| April 15, 2024 |
Akanda Announces No Equity Financing Until Further Notice Exhibit 99.1 Akanda Announces No Equity Financing Until Further Notice London, UK April 15, 2024 –Akanda Corp. (“Akanda” or the “Company”) (NASDAQ: AKAN), an international medical cannabis company, previously announced the completion of several public offerings and the sale of its indirectly wholly-owned Portuguese subsidiary, RPK BioPharma Unipessoal, LDA (“RPK”) now announces its plans to pause |
|
| April 12, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2024 Commission File Number: 001-41324 AKANDA CORP. (Name of registrant) 1a, 1b Learoyd Road New Romney TN28 8XU, United Kingdom (Address of principal executive office) Indicate by check |
|
| April 12, 2024 |
Exhibit 99.1 Akanda Looks to Commercialize and Capitalize on Germany’s Legalization of Cannabis, Opening Path to $3BN Market London, UK April 12, 2024 –Akanda Corp. (“Akanda” or the “Company”) (NASDAQ: AKAN), an international medical cannabis company, announces its plans to evaluate and pursue strategic investments in the expanded legalized German market. On April 1, 2024 Germany became the third |
|
| April 12, 2024 |
Akanda Announces Plans to Enter Blockchain and AI Technology Sector Exhibit 99.2 Akanda Announces Plans to Enter Blockchain and AI Technology Sector London,UK April 12, 2024 –Akanda Corp. (“Akanda” or the “Company”) (NASDAQ: AKAN), an international medical cannabis company, Akanda Corp. announces its plans to enter the blockchain and artificial intelligence sector of the cannabis industry. With an increasingly complex and global supply chain for the international |
|
| April 11, 2024 |
Akanda Corp. Announces Closing of the Sale of RPK Exhibit 99.1 Akanda Corp. Announces Closing of the Sale of RPK London, April 11, 2024 – on April 1 2024, Akanda Corp. ("Akanda" or the “Company”) (NASDAQ: AKAN), an international medical cannabis company, Akanda Corp. completed the transaction with Somai Pharmaceuticals Ltd. (the “Buyer”) for the sale of RPK, its indirect wholly-owned Portuguese subsidiary. Pursuant to the provisions set forth in |
|
| April 11, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2024 Commission File Number: 001-41324 AKANDA CORP. (Name of registrant) 1a, 1b Learoyd Road New Romney TN28 8XU, United Kingdom (Address of principal executive office) Indicate by check |
|
| April 11, 2024 |
Akanda Corp. Announces Plan to Integrate Technology Solutions to Capture UK Market Exhibit 99.2 Akanda Corp. Announces Plan to Integrate Technology Solutions to Capture UK Market London, Thursday April 11, 2024 – on April 4, 2024, Akanda Corp. (“Akanda” or the “Company”) (NASDAQ: AKAN), an international medical cannabis company announced its wholly-owned United Kingdom (UK) subsidiary, Canmart, plans to develop its social shopping capability by integrating with META, to create a |
|
| March 28, 2024 |
Exhibit 10.1 CONSULTING AGREEMENT IR Agency LLC (the “Consultant” or “IR Agency”) is pleased to provide certain consulting services to Akanda Corp (“you,” the “Client” or the “Company”) as more fully described in this agreement (the Agreement”). This Agreement sets forth the terms and conditions pursuant to which the Company engages the Consultant to provide such services. 1. Consulting Services. |
|
| March 28, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2024 Commission File Number: 001-41324 AKANDA CORP. (Name of registrant) 1a, 1b Learoyd Road New Romney TN28 8XU, United Kingdom (Address of principal executive office) Indicate by check |
|
| March 28, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2024 Commission File Number: 001-41324 AKANDA CORP. (Name of registrant) 1a, 1b Learoyd Road New Romney TN28 8XU, United Kingdom (Address of principal executive office) Indicate by check |
|
| March 28, 2024 |
Exhibit 99.2 Akanda Corp. Announces Canmart’s Plans for Facebook and Instagram Social Shopping Technology Integration London, March 28, 2024 – on March 28, 2024, Akanda Corp. (“Akanda” or the “Company”) (NASDAQ: AKAN), an international medical cannabis company, Akanda Corp. announced its wholly-owned United Kingdom (UK) subsidiary, Canmart, plans to develop its social shopping capability by integr |
|
| March 28, 2024 |
Exhibit 99.1 Akanda Corp. Announces Strategic Plan to Evaluate and Enter Bitcoin, Blockchain, AI Segments of the Cannabis Market London, March 28, 2024 – on March 28, 2024, Akanda Corp. (“Akanda” or the “Company”) (NASDAQ: AKAN), an international medical cannabis company, Akanda Corp. announced aspirations to enter technology segments of the cannabis industry. The Company is evaluating potential o |
|
| March 27, 2024 |
FORM OF PRE-FUNDED WARRANT TO PURCHASE COMMON SHARES AKANDA CORP. Exhibit 4.1 FORM OF PRE-FUNDED WARRANT TO PURCHASE COMMON SHARES AKANDA CORP. Warrant Shares: Initial Exercise Date: [], 2024 THIS PRE-FUNDED WARRANT TO PURCHASE COMMON SHARES (the “Warrant”) certifies that, for value received, or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the d |
|
| March 27, 2024 |
AKANDA CORP. UNDERWRITING AGREEMENT Exhibit 1.1 AKANDA CORP. UNDERWRITING AGREEMENT March 24, 2024 Univest Securities, LLC 75 Rockefeller Plaza, Suite 1838 New York, NY 10019 As Representative of the Underwriters named on Schedule A hereto Ladies and Gentlemen: The undersigned, AKANDA CORP., a corporation organized under the laws of the Province of Ontario (collectively with its subsidiaries and affiliates, including, without limita |
|
| March 27, 2024 |
Akanda Corp. Announces Closing of Underwritten Public Offering Exhibit 99.1 Akanda Corp. Announces Closing of Underwritten Public Offering London, March 27, 2024 – On March 24, 2024, Akanda Corp. ("Akanda" or the “Company”) (NASDAQ: AKAN), an international medical cannabis company, entered into an underwriting agreement (the “Underwriting Agreement”) with Univest Securities, LLC (“Univest”) as the underwriter in connection with the issuance and sale by the Co |
|
| March 27, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2024 Commission File Number: 001-41324 AKANDA CORP. (Name of registrant) 1a, 1b Learoyd Road New Romney TN28 8XU, United Kingdom (Address of principal executive office) Indicate by check |
|
| March 26, 2024 |
PROSPECTUS Filed Pursuant to Rule 424(b)(4) Registration Nos. 333-277182 3,087,443 Common Shares 37,997,190 Pre-Funded Warrants to Purchase 37,997,190 Common Shares 37,997,190 Common Shares Underlying the Pre-Funded Warrants Akanda Corp. We are offering 3,087,443 Common Shares, no par value (the “Common Shares”) at a public offering price of $0.1217. We are also offering 37,997,190 pre-funded warr |
|
| March 25, 2024 |
Akanda Corp. Announces Pricing of Underwritten Public Offering Exhibit 99.1 Akanda Corp. Announces Pricing of Underwritten Public Offering London, March 25, 2024 – Akanda Corp. ("Akanda" or the “Company”) (NASDAQ: AKAN), an international medical cannabis company, today announced that it has entered into a firm commitment underwriting agreement with Univest Securities, LLC, as underwriter, whereby Univest has agreed to purchase up to 41,084,634 common shares o |
|
| March 25, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2024 Commission File Number: 001-41324 AKANDA CORP. (Name of registrant) 1a, 1b Learoyd Road New Romney TN28 8XU, United Kingdom (Address of principal executive office) Indicate by check |
|
| March 22, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2024 Commission File Number: 001-41324 AKANDA CORP. (Name of registrant) 1a, 1b Learoyd Road New Romney TN28 8XU, United Kingdom (Address of principal executive office) Indicate by check |
|
| March 18, 2024 |
Akanda corp. 1a, 1b Learoyd Road New Romney TN28 8XU United Kingdom Akanda corp. 1a, 1b Learoyd Road New Romney TN28 8XU United Kingdom March 18, 2024 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, NE Washington, D.C. 20549 Attn: Tamika Sheppard Re: Akanda Corp. (the “Company”) Registration Statement on Form F-1 File No. 333-277182 (the “Registration Statement”) Dear Ms. Sheppard: Pursuant to |
|
| March 18, 2024 |
Univest Securities LLC 75 Rockefeller Plaza, Suite 1838 New York, NY 10019 Univest Securities LLC 75 Rockefeller Plaza, Suite 1838 New York, NY 10019 March 18, 2024 VIA EDGAR U. |
|
| March 18, 2024 |
Univest Securities LLC 75 Rockefeller Plaza, Suite 1838 New York, NY 10019 Univest Securities LLC 75 Rockefeller Plaza, Suite 1838 New York, NY 10019 March 18, 2024 VIA EDGAR U. |
|
| March 18, 2024 |
Univest Securities LLC 75 Rockefeller Plaza, Suite 1838 New York, NY 10019 Univest Securities LLC 75 Rockefeller Plaza, Suite 1838 New York, NY 10019 March 18, 2024 VIA EDGAR U. |
|
| March 18, 2024 |
Akanda corp. 1a, 1b Learoyd Road New Romney TN28 8XU United Kingdom Akanda corp. 1a, 1b Learoyd Road New Romney TN28 8XU United Kingdom March 18, 2024 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, NE Washington, D.C. 20549 Attn: Tamika Sheppard Re: Akanda Corp. (the “Company”) Registration Statement on Form F-1 File No. 333-277182 (the “Registration Statement”) Dear Ms. Sheppard: Reference i |
|
| March 18, 2024 |
Akanda corp. 1a, 1b Learoyd Road New Romney TN28 8XU United Kingdom Akanda corp. 1a, 1b Learoyd Road New Romney TN28 8XU United Kingdom March 18, 2024 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, NE Washington, D.C. 20549 Attn: Tamika Sheppard Re: Akanda Corp. (the “Company”) Registration Statement on Form F-1 File No. 333-277182 (the “Registration Statement”) Dear Ms. Sheppard: Pursuant to |
|
| March 15, 2024 |
As filed with the Securities and Exchange Commission on March 15, 2024 As filed with the Securities and Exchange Commission on March 15, 2024 Registration No. |
|
| March 11, 2024 |
Exhibit 107 Calculation Of Filing Fee Table F-1 (Form Type) Akanda Corp. (Exact name of Registrant as Specified in its Charter) Security Type (1) Security Class Title Amount Registered (1) Proposed Maximum Offering Price Per Share Proposed Maximum Aggregate Offering Price (2) Fee Rate Amount of Registration Fee (3) Fees to Be Paid Common Shares, par value $0.0001 per share, to be sold by the Regis |
|
| March 11, 2024 |
AKANDA CORP. UNDERWRITING AGREEMENT Exhibit 1.1 AKANDA CORP. UNDERWRITING AGREEMENT , 2024 Univest Securities, LLC 75 Rockefeller Plaza, Suite 1838 New York, NY 10019 As Representative of the Underwriters named on Schedule A hereto Ladies and Gentlemen: The undersigned, AKANDA CORP., a corporation organized under the laws of the Province of Ontario (collectively with its subsidiaries and affiliates, including, without limitation, al |
|
| March 11, 2024 |
As filed with the Securities and Exchange Commission on March 11, 2024 As filed with the Securities and Exchange Commission on March 11, 2024 Registration No. |
|
| March 11, 2024 |
FORM OF PRE-FUNDED WARRANT TO PURCHASE COMMON SHARES AKANDA CORP. Exhibit 10.19 FORM OF PRE-FUNDED WARRANT TO PURCHASE COMMON SHARES AKANDA CORP. Warrant Shares: Initial Exercise Date: [], 2024 THIS PRE-FUNDED WARRANT TO PURCHASE COMMON SHARES (the “Warrant”) certifies that, for value received, or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the |
|
| March 11, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2024 Commission File Number: 001-41324 AKANDA CORP. (Name of registrant) 1a, 1b Learoyd Road New Romney TN28 8XU, United Kingdom (Address of principal executive office) Indicate by check |
|
| March 11, 2024 |
Exhibit 99.2 AKANDA CORP. Security Class: Common Shares FORM OF PROXY Annual General & Special Meeting to be held on Friday, March 22, 2024 This Form of Proxy is solicited by and on behalf of Management. Notes to proxy Every holder has the right to appoint some other person or company of their choice, who need not be a holder, to attend and act on their behalf at the meeting or any adjournment or |
|
| March 11, 2024 |
Exhibit 99.1 AKANDA CORP. NOTICE OF ANNUAL GENERAL AND SPECIAL MEETING TO BE HELD ON MARCH 22, 2024 AND MANAGEMENT INFORMATION CIRCULAR MARCH 12, 2024 - i - AKANDA CORP. NOTICE OF ANNUAL GENERAL AND SPECIAL MEETING OF SHAREHOLDERS (the “Notice”) NOTICE IS HEREBY GIVEN that an annual general and special meeting (the “Meeting”) of the holders (the “Shareholders”) of common shares (the “Common Shares |
|
| March 11, 2024 |
Exhibit 10.25 FINDER’S AGREEMENT THIS FINDER’S FEE AGREEMENT is made as of the 12th day of June, 2021 (the “Effective Date”) between Cannera Holdings Ltd, a British Columbia Corporation having an office at [***] (the “Finder”) and AKANDA CORP., a United Kingdom Corporation having an office situated 1a, 1b Learoyd Road New Romney TN28 8XU, United Kingdom (the “Company”). WHEREAS the Finder has agre |
|
| March 6, 2024 |
FORM OF PRE-FUNDED WARRANT TO PURCHASE COMMON SHARES AKANDA CORP. Exhibit 4.1 FORM OF PRE-FUNDED WARRANT TO PURCHASE COMMON SHARES AKANDA CORP. Warrant Shares: Initial Exercise Date: March , 2024 THIS PRE-FUNDED WARRANT TO PURCHASE COMMON SHARES (the “Warrant”) certifies that, for value received, or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after t |
|
| March 6, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2024 Commission File Number: 001-41324 AKANDA CORP. (Name of registrant) 1a, 1b Learoyd Road New Romney TN28 8XU, United Kingdom (Address of principal executive office) Indicate by check |
|
| March 6, 2024 |
Exhibit 1.1 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (this “Agreement”) is dated as of March 4, 2024, between Akanda Corp., a Canadian corporation incorporated under the Business Corporations Act (Ontario) (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”) |
|
| March 5, 2024 |
367,870 common shares Pre-funded warrants to purchase up to 373,002 common shares AKANDA CORP. Prospectus Supplement Filed pursuant to Rule 424(b)(5) (To Prospectus dated January 29, 2024) Registration No. |
|
| March 5, 2024 |
Exhibit 1.1 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (this “Agreement”) is dated as of March 1, 2024, between Akanda Corp., a Canadian corporation incorporated under the Business Corporations Act (Ontario) (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”) |
|
| March 5, 2024 |
FORM OF PRE-FUNDED WARRANT TO PURCHASE COMMON SHARES AKANDA CORP. Exhibit 4.1 FORM OF PRE-FUNDED WARRANT TO PURCHASE COMMON SHARES AKANDA CORP. Warrant Shares: Initial Exercise Date: March , 2024 THIS PRE-FUNDED WARRANT TO PURCHASE COMMON SHARES (the “Warrant”) certifies that, for value received, or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after t |
|
| March 5, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2024 Commission File Number: 001-41324 AKANDA CORP. (Name of registrant) 1a, 1b Learoyd Road New Romney TN28 8XU, United Kingdom (Address of principal executive office) Indicate by check |
|
| March 1, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2024 Commission File Number: 001-41324 AKANDA CORP. (Name of registrant) 1a, 1b Learoyd Road New Romney TN28 8XU, United Kingdom (Address of principal executive office) Indicate by check |
|
| March 1, 2024 |
367,870 common shares Pre-funded warrants to purchase up to 361,972 common shares AKANDA CORP. Prospectus Supplement Filed pursuant to Rule 424(b)(5) (To Prospectus dated January 29, 2024) Registration No. |
|
| February 29, 2024 |
Exhibit 99.3 ESCROW AGREEMENT THIS ESCROW AGREEMENT is dated as of February 28, 2024 BETWEEN: AKANDA CORP. (“Akanda”) AND: SOMAI PHARMACEUTICALS LTD. (“Somai”) AND: LAWSON LUNDELL LLP, a limited liability partnership formed under the laws of the Province of British Columbia (the “Escrow Agent”). WHEREAS: A. Pursuant to a Non-Binding Letter of Intent made as of November 21, 2023 between Akanda and |
|
| February 29, 2024 |
Exhibit 99.2 SHARE PURCHASE AGREEMENT AMONG AKANDA CORP. - and - CANNAHEALTH LIMITED - and - HOLIGEN LIMITED - and - SOMAI PHARMACEUTICALS UNIPESSOAL, LDA. Dated as of February 28, 2024 TABLE OF CONTENTS Page ARTICLE 1 DEFINITIONS 1 1.1 Definitions. 1 1.2 Exhibits, Schedules. 9 ARTICLE 2 PURCHASE OF PURCHASED INTEREST 9 2.1 Purchase of Purchased Interest 9 2.2 Purchase Price. 9 2.3 Closing. 10 2.4 |
|
| February 29, 2024 |
Exhibit 99.1 Akanda Corp. Signs Share Purchase and Escrow Agreements for the Sale of Portuguese Assets to Somai Pharmaceuticals London, February 29, 2024 – Akanda Corp. (“Akanda” or the “Company”) (NASDAQ: AKAN), an international medical cannabis company, today announced the signing of a definitive Share Purchase Agreement and Escrow Agreement with Somai Pharmaceuticals Unipessoal, LDA (“Somai”), |
|
| February 29, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2024 Commission File Number: 001-41324 AKANDA CORP. (Name of registrant) 1a, 1b Learoyd Road New Romney TN28 8XU, United Kingdom (Address of principal executive office) Indicate by che |
|
| February 22, 2024 |
United States securities and exchange commission logo February 22, 2024 Katie Fields Interim Chief Executive Officer Akanda Corp. |
|
| February 21, 2024 |
Akanda Corp. Provides Further Update on Annual Meeting of its Shareholders Exhibit 99.1 Akanda Corp. Provides Further Update on Annual Meeting of its Shareholders London, February 20, 2024 – Akanda Corp. (“Akanda” or the “Company”) (NASDAQ: AKAN), an international medical cannabis company, today announces that it has received an order from the Ontario Superior Court of Justice (the “Court”) permitting Akanda to hold its annual meeting of shareholders (the “Meeting”) on o |
|
| February 21, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2024 Commission File Number: 001-41324 AKANDA CORP. (Name of registrant) 1a, 1b Learoyd Road New Romney TN28 8XU, United Kingdom (Address of principal executive office) Indicate by che |
|
| February 20, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2024 Commission File Number: 001-41324 AKANDA CORP. (Name of registrant) 1a, 1b Learoyd Road New Romney TN28 8XU, United Kingdom (Address of principal executive office) Indicate by che |
|
| February 20, 2024 |
Exhibit 10.23 NON-BINDING LETTER OF INTENT STRICTLY PRIVATE AND CONFIDENTIAL November 21st, 2023 Akanda Corp. Re: Proposed Purchase of the Shares of RPK Biopharma, Unipessoal, LDA This letter of intent (“Letter of Intent”) is presented further to the discussions to date between Holigen Limited (the “Seller”), a subsidiary of Akanda Corp. (“Akanda”) and Somai Pharmaceuticals Ltd (“Somai” or the “Bu |
|
| February 20, 2024 |
AKAN / Akanda Corp. / Halo Collective Inc. - SCHEDULE 13D Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 AKANDA CORP. (Name of Issuer) Common Shares, no par value (Title of Class of Securities) 00971M205 (CUSIP Number) Katie Field, Chairman & CEO Halo Collective Inc. 65 Queen Street W., Suite 815 Toronto, Ontario M5H 2M5 Canada Copy to: Richard Raymer Dorsey & Whitney LLP 161 |
|
| February 20, 2024 |
Note Conversion Agreement July 25, 2023 Exhibit 10.14 Note Conversion Agreement July 25, 2023 This Note Conversion Agreement (the “Agreement”) is made as of July 25, 2023 between Halo Collective Inc., an Ontario corporation (the “Holder”), and Akanda Corp., an Ontario corporation (the “Debtor”), in connection with a promissory note with a principal amount of US$328,000 dated January 26, 2023 issued by the Debtor to the Holder (the “Note |
|
| February 20, 2024 |
As filed with the Securities and Exchange Commission on February 20, 2024 As filed with the Securities and Exchange Commission on February 20, 2024 Registration No. |
|
| February 20, 2024 |
Exhibit 99.2 Akanda Corp. 1a, 1b Learoyd Road New Romney TN28 8XU United Kingdom February 20, 2024 Re: Notice to Shareholders – Application for Extension of Time to Hold Annual General Meeting Dear valued shareholders of Akanda Corp. (“Akanda”): Akanda is a corporation incorporated pursuant to the Business Corporations Act (Ontario) (“OBCA”) under the laws of the Province of Ontario, Canada. Pursu |
|
| February 20, 2024 |
AKAN / Akanda Corp. / Halo Collective Inc. - AMENDMENT NO. 1 TO SCHEDULE 13G Passive Investment SC 13G/A 1 sc13ga.htm AMENDMENT NO. 1 TO SCHEDULE 13G SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 Amendment No. 1 to SCHEDULE 13G INFORMATION STATEMENT PURSUANT TO RULES 13d-1 AND 13d-2 UNDER THE SECURITIES EXCHANGE ACT OF 1934 AKANDA CORP. (Name of Issuer) Common Shares, no par value (Title of Class of Securities) 00971M205 (CUSIP Number) May 27, 2023 (Date of Event Which Requires Fil |
|
| February 20, 2024 |
Exhibit 107 Calculation Of Filing Fee Table F-1 (Form Type) Akanda Corp. (Exact name of Registrant as Specified in its Charter) Security Type (1) Security Class Title Amount Registered (1) Proposed Maximum Offering Price Per Share Proposed Maximum Aggregate Offering Price (2) Fee Rate Amount of Registration Fee (3) Fees to Be Paid Common Shares, par value $0.0001 per share, to be sold by the Regis |
|
| February 20, 2024 |
AKAN / Akanda Corp. / Halo Collective Inc. - SCHEDULE 13D AMENDMENT NO. 1 Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 1 to SCHEDULE 13D Under the Securities Exchange Act of 1934 AKANDA CORP. (Name of Issuer) Common Shares, no par value (Title of Class of Securities) 00971M205 (CUSIP Number) Katie Field, Chairman & CEO Halo Collective Inc. 65 Queen Street W., Suite 815 Toronto, Ontario M5H 2M5 Canada Copy to: Richard Raymer Dorse |
|
| February 20, 2024 |
INDEPENDENT CONTRACTOR AGREEMENT Exhibit 10.21 INDEPENDENT CONTRACTOR AGREEMENT This Independent Contractor Agreement (“Agreement”), effective as of , (the “Effective Date”), is between Akanda Corp. (“Company”) and Kiran Sidhu (“Contractor”). Scope of Services. 1. Company retains Contractor for consulting work pertaining to assisting the Company in increasing its enterprise value, in which the responsibilities of the Contractor a |
|
| February 20, 2024 |
Significant Subsidiaries of Akanda Corp. Exhibit 21.1 Significant Subsidiaries of Akanda Corp. The following corporations are wholly owned subsidiaries of Akanda Corp: Subsidiary Jurisdiction Canmart Limited England and Wales Cannahealth Limited Malta Bophelo Holdings Ltd. United Kingdom Bophelo Bio Science and Wellness (Pty) Ltd.* Lesotho Holigen Holdings Limited Malta RPK Biopharma Unipessoal, LDA Portugal 1371011 BC Ltd Canada * Bophe |
|
| February 20, 2024 |
Akanda Corp. Provides Update on Annual Meeting of its Shareholders Exhibit 99.1 Akanda Corp. Provides Update on Annual Meeting of its Shareholders London, February 20, 2024 – Akanda Corp. (“Akanda” or the “Company”), an international medical cannabis company, today announces that it has made an application to the Ontario Superior Court of Justice (the “Court”) to extend the deadline for it to hold its annual meeting of shareholders (the “Meeting”) from February 2 |
|
| February 20, 2024 |
AMENDMENT NO. 1 TO NON-BINDING LETTER OF INTENT Exhibit 10.24 AMENDMENT NO. 1 TO NON-BINDING LETTER OF INTENT This Amendment No. 1 to Non-Binding Letter of Intent (“Amendment”) is entered into and made effective as of January 31, 2024 by and between Akanda Corp. (“Akanda”) and Somai Pharmaceuticals Ltd. (“Somai”). Akanda and Somai are collectively referred to as the “Parties” and singularly referred to as “Party.” RECITALS WHEREAS, Akanda and S |
|
| February 13, 2024 |
Akanda Corp. Discusses Positive Trends in UK Cannabis Market Exhibit 99.1 Akanda Corp. Discusses Positive Trends in UK Cannabis Market London, February 13, 2024 – Akanda Corp. NASDAQ: AKAN ("Akanda" or the “Company”), provides an overview of the growing cannabis market in the United Kingdom and promising trends among patients. 2023 was a dynamic year for the UK cannabis market. Patients grew and so did imports. November of 2023 marked five years since the U |
|
| February 13, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2024 Commission File Number: 001-41324 AKANDA CORP. (Name of registrant) 1a, 1b Learoyd Road New Romney TN28 8XU, United Kingdom (Address of principal executive office) Indicate by che |
